The effects of adulterants and selected ingested compounds on drugs-of-abuse testing in urine

American Journal of Clinical Pathology

Volumn 128, Issue 3, 2007, Pages 491-503

  Dasgupta, Amitava ^a,b  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

Adulterants; Drugs of abuse; Hemp oil; Nitrite; Poppy seed cake; Potassium chlorochromate

Indexed keywords

AMPHETAMINE; BLEACHING AGENT; CANNABIS; COCAINE; CODEINE; DETERGENT; GLUTARALDEHYDE; METHAMPHETAMINE; MORPHINE; OPIATE; PHENCYCLIDINE; SODIUM CHLORIDE; VINEGAR;

CONTROLLED STUDY; DRUG ABUSE; DRUG SCREENING; GAS CHROMATOGRAPHY; HAIR ANALYSIS; HUMAN; HUMAN EXPERIMENT; LEMON JUICE; MASS SPECTROMETRY; PRIORITY JOURNAL; REVIEW; SALIVA ANALYSIS; URINALYSIS; URINE LEVEL;

DRUG CONTAMINATION; GUIDELINES; HUMANS; SENSITIVITY AND SPECIFICITY; SORPTION DETOXIFICATION; STREET DRUGS; SUBSTANCE ABUSE DETECTION;

EID: 34748817630     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/FQY06F8XKTQPM149     Document Type: Review

References (72)

1. Substance Abuse and Mental Health Services Administration, Department of Health and Human Services. Mandatory Guidelines for Federal Workplace Drug Testing Programs. Fed Regist. 1988;53:11970-11980.
2. Substance Abuse and Mental Health Services Administration, Department of Health and Human Services. Mandatory Guidelines for Federal Workplace Drug Testing Programs. Fed Regist. 1994;59:29908-29912.
3. Substance Abuse and Mental Health Services Administration, Department of Health and Human Services. Mandatory Guidelines for Federal Workplace Drug Testing Programs. Fed Regist. 1997;62:51118-51120.
4. Substance Abuse and Mental Health Services Administration, Department of Health and Human Services. Mandatory Guidelines for Federal Workplace Drug Testing Programs. Fed Regist. 2004;19643-19673.
5. Paul B, Jacobs A. Spectrophotometric detection of iodide and chromic (III) in urine after oxidation to iodine and chromate (VI). J Anal Toxicol. 2005;29:658-663.
6. Burrows DL, Nicolaides A, Rice PJ, et al. Papain: a novel urine adulterant. J Anal Toxicol. 2005;29:275-295.
7. George S, Braithwaite RA. An investigation into the extent of possible dilution of specimens received for urinary drugs of abuse screening. Addiction. 1995;90:967-970.
8. Needleman SD, Porvaznik M. Creatinine analysis in single collection urine specimens. J Forensic Sci. 1992;37:1125-1133.
9. Beck O, Bohlin M, Bragd F, et al. Adulteration of urine drug testing: an exaggetated cause of concern [in Swedish] Lakartidningen. 2000;97:703-706.
10. Fraser AD, Zamecnik J. Impact of lowering the screening and confirmation cutoff values for urine drug testing based on dilution indicators. Ther Drug Monit. 2003;25:723-727.
11. Soldin SJ, Morales AJ, D'Angelo LJ, et al. The importance of lowering the cut-off concentrations of urine screening and confirmatory tests for benzoylecgonine/cocaine [abstract]. Clin Chem. 1991;37:993.
12. Luzzi VI, Saunders AN, Koenig JW, et al. Analytical performance of immunoassays for drugs of abuse below established cutoff values. Clin Chem. 2004;50:717-722.
13. Department of Transportation. Part 40: procedures for transportation workplace drug and alcohol testing. Fed Regist. 2000;65:79462-79579.
14. Edgell K, Caplan YH, Glass LR, et al. The defined HHS/DOT substituted urine criteria validated through controlled hydration study. J Anal Toxicol. 2002;26:419-423.
15. Barbanel CS, Winkelman JW, Fischer GA, et al. Confirmation of the Department of Transportation criteria for a substituted urine specimen. J Occup Environ Med. 2002;44:407-416.
16. Cook JD, Hannon MW, Vo T, et al. Evaluation of freezing point depression for classifying random urine specimens defined as substituted under HHS/DOT criteria. J Anal Toxicol. 2002;26:424-429.
17. Cone EJ, Lange R, Darwin WD. In vivo adulteration: excess fluid ingestion causes false negative marijuana and cocaine urine test results. J Anal Toxicol. 1998;22:460-473.
18. Mikkelsen SL, Ash KO. Adulterants causing false negatives in illicit drug testing. Clin Chem. 1988;34:2333-2336.
19. McNamara CE, Perry NB, Follett JM, et al. A new glucosyl feruloyl quinic acid as a potential marker for roots and rhizomes of goldenseal, Hydrastis canadenis. J Nat Prod. 2004;67:1818-1822.
20. Deventer K, Delbeke FT, Roels K, et al. Screening for 18 diuretics and probenecid in doping analysis by liquid chromatography-tandem mass spectrometry. Biomed Chromatogr. 2002;16:529-535.
21. Warner A. Interference of household chemicals in immunoassay methods for drugs of abuse. Clin Chem. 1989;35:648-651.
22. Uebel RA, Wium CA. Toxicological screening for drugs of abuse in samples adulterated with household chemicals. S Afr Med J. 2002;92:547-549.
23. Schwarzhoff R, Cody JT. The effects of adulterating agents on FPIA analysis of urine for drugs of abuse. J Anal Toxicol. 1993;17:14-17.
24. Baiker C, Serrano L, Lindner B. Hypochlorite adulteration of urine causing decreased concentration of delta-9-THC-COOH by GC/MS. J Anal Toxicol. 1994;18:101-103.
25. Stolk LM, Scheijen JL. Urine adulteration with denture cleaning tablets [letter]. J Anal Toxicol. 1997;21:403.
26. Pearson SD, Ash KO, Urry FM. Mechanism of false-negative urine cannabinoid immunoassay screens by Visine eyedrops. Clin Chem. 1989;35:636-638.
27. Fogerson R, Schoendorfer D, Fay J, et al. Qualitative detection of opiates in sweat by EIA and GC-MS. J Anal Toxicol. 1997;21:451-458.
28. Rojsitthisak P, Wichitnithad W, Pipitharome O, et al. Simple HPLC determination of benzalkonium chloride in ophthalmic formulations containing antazoline and tetrahydrozoline. PDA J Pharm Sci Technol. 2005;59:323-327.
29. Wu A, Bristol B, Sexton K, et al. Adulteration of urine by Urine Luck. Clin Chem. 1999;45:1051-1057.
30. Paul BD, Martin KK, Maguilo J Jr, et al. Effects of pyridinium chlorochromate adulterant (Urine Luck) on testing of drugs of abuse and a method for quantitative detection of chromium (VI) in urine. J Anal Toxicol. 2000;24:233-237.
31. Dasgupta A, Wahed A, Wells A. Rapid spot tests for detecting the presence of adulterants in urine specimens submitted for drug testing. Am J Clin Pathol. 2002;117:325-329.
32. Ferslew KE, Hagardorn AN, Roberts TA. Capillary ion electrophoresis of endogenous anions and anionic adulterants in human urine. J Forensic Sci. 2001;46:615-626.
33. Ferslew KE, Nicolaides AN, Robert TA. Determination of Chromate adulteration of human urine by automated colorimetric and capillary ion electrophoretic analyses. J Anal Toxicol. 2003;27:36-39.
34. Paul BD. Six spectroscopic methods for detection of oxidants in urine: implication in differentiation of normal and adulterated urine. J Anal Toxicol. 2004;28:599-608.
35. 9-THC-9-COOH. J Anal Toxicol. 1997;20:240-242.
36. Tsai SC, ElSohly MA, Dubrovsky T, et al. Determination of five abused drugs in nitrite-adulterated urine by immunoassay and gas chromatography-mass spectrometry. J Anal Toxicol. 1998;22:474-480.
37. Tsai LS, ElSohly MA, Tsai SF, et al. Investigation of nitrite adulteration on the immunoassay and GC-MS analysis of cannabinoids in urine specimens. J Anal Toxicol. 2000;24:708-714.
38. Urry F, Komaromy-Hiller G, Staley B, et al. Nitrite adulteration of workplace drug testing specimens: sources and associated concentrations of nitrite and distinction between natural sources and adulteration. J Anal Toxicol. 1998;22:89-95.
39. Singh J, Elberlind JA, Hemphill DG, et al. The measurement of nitrite in adulterated urine samples by high performance ion chromatography. J Anal Toxicol. 1999;23:137-140.
40. Kinkennon AE, Black DL, Robert TA, et al. Analysis of nitrite in adulterated urine samples by capillary electrophoresis. J Forensic Sci. 2004;49:1094-1100.
41. Cody JT, Valtier S. Effects of Stealth adulteration on immunoassay testing for drugs of abuse. J Anal Toxicol. 2001;25:466-470.
42. Cody JT, Valtier S, Kuhlman J. Analysis of morphine and codeine in samples adulterated with Stealth. J Anal Toxicol. 2001;25:572-575.
43. Valtier S, Cody JT. A procedure for the detection of Stealth adulterant in urine samples. Clin Lab Sci. 2002;15:111-115.
44. George S, Braithwaite RA. The effect of glutaraldehyde adulteration of urine specimens on Syva EMIT II drugs of abuse assays. J Anal Toxicol. 1996;20:195-196.
45. Wu AH, Forte E, Casella G, et al. CEDIA for screening drugs of abuse in urine and the effect of adulterants. J Forensic Sci. 1995;40:614-618.
46. Goldberger BA, Caplan YH. Effect of glutaraldehyde (UrinAid) on detection of abused drugs in urine by immunoassay [letter]. Clin Chem. 1994;40:1605-1606.
47. Wu A, Schmalz J, Bennett W. Identification of Urin-Aid adulterated urine specimens by fluorometric analysis [letter]. Clin Chem. 1994;40:845-846.
48. Cody JT, Schwarzhoff RH. Impact of adulterants on RIA analysis of urine for drugs of abuse. J Anal Toxicol. 1989;13:277-284.
49. Lewis SA, Lewis LA, Tuinman A. Potassium nitrite reaction to 11-nor-delta 9-tetrahydrocannabinol-9-carboxylic acid in urine in relation to the drug screening analysis. J Forensic Sci. 1999;44:951-955.
50. 9-THC-9-carboxylic acid in urine. J Anal Toxicol. 2002;26:460-463.
51. Jones JT, Esposito FM. An assay evaluation of the methylene blue method for the detection of anionic surfactants in urine. J Anal Toxicol. 2000;24:323-327.
52. Peace MR, Tarnai LD. Performance evaluation of three on-site adulteration detection devices for urine specimens. J Anal Toxicol. 2002;26:464-470.
53. King EJ. Performance of AdultaCheck 4 test strips for the detection of adulteration at the point of collection of urine specimens used for drugs-of-abuse testing. J Anal Toxicol. 1999;23:72.
54. Dasgupta A, Chughtai O, Hannah C, et al. Comparison of spot tests with AdultaCheck 6 and Intect 7 urine test strips for detecting the presence of adulterants in urine specimens. Clin Chim Acta. 2004;348:19-25.
55. Rollins DE, Wilkins DG, Krueger GG, et al. The effect of hair color on the incorporation of codeine into human hair. J Anal Toxicol. 2003;27:545-551.
56. Kintz P, Bernhard W, Villain M, et al. Detection of cannabis use in drivers with the Drugwipe device and by GC-MS after intercept device collection. J Anal Toxicol. 2005;29:724-727.
57. Kadehjian L. Legal issues in oral fluid testing. Forensic Sci Int. 2005;150:151-160.
58. Wong RC, Tran M, Tung JK. Oral fluid testing: effects of adulterants and foodstuffs. Forensic Sci Int. 2005;150:175-180.
59. Struempler RE. Excretion of codeine and morphine following ingestion of poppy seeds. J Anal Toxicol. 1987;11:97-99.
60. Jackson GF, Saddy JJ, Poklis A. The determination of morphine in urine and oral fluid following ingestion of poppy seeds. J Anal Toxicol. 2003;27:449-452.
61. Moeller MR, Hammer K, Engel O. Poppy seed consumption and toxicological analysis of blood and urine samples. Forensic Sci Int. 2004;143:183-186.
62. Hill V, Cairns T, Cheng CC, et al. Multiple aspects of hair analysis for opiates: methodology, clinical and workplace population, codeine and poppy seed ingestion. J Anal Toxicol. 2005;29:696-703.
63. Rohrig TP, Moore C. Urinary excretion of benzoylecgonine following ingestion of Health Inca Tea. Forensic Sci Int. 1991;49:57-64.
64. Turner M, McCrory P, Johnston A. Time for tea anyone? Br J Sports Med. 2005;39:e37.
65. Mule SJ, Lomax P, Gross SJ. Active and realistic passive marijuana exposure tested by three immunoassays and GC/MS. J Anal Toxicol. 1988;12:113-116.
66. Niedbala S, Kardos S, Salamone D, et al. Passive cannabis smoke exposure and oral fluid testing. J Anal Toxicol. 2004;28:546-552.
67. Niedbala RS, Kardos KW, Fritch D, et al. Passive cannabis smoke exposure and oral fluid testing, II: two studies of extreme cannabis smoke exposure in a motor vehicle. J Anal Toxicol. 2005;29:607-615.
68. Struempler RE, Nelson G, Urry TM. A positive cannabinoid workplace drug test following the ingestion of hemp seed oil. J Anal Toxicol. 1997;21:283-285.
69. Alt A, Reinhardt G. Positive cannabis results in urine and blood samples after consumption of hemp food products [letter]. J Anal Toxicol. 1998;22:80-81.
70. Gibson CR, Williams RD, Browder RO. Analysis of Hempen Ale for cannabinoids [letter]. J Anal Toxicol. 1998;22:179.
71. Leson G, Pless P, Grotenhermen F, et al. Evaluating the impact of hemp food consumption on workplace drug tests. J Anal Toxicol. 2001;25:691-698.
72. Gustafson R, Levine B, Stout P, et al. Urinary cannabinoid detection times after controlled oral administration of delta-9-tetrahydrocannabinol to humans. Clin Chem. 2003;49:1114-1124.